People with diabetes and others taking glucagon-like peptide-1 receptor agonists (GLP-1RAs) should be monitored for nutritional deficiencies and muscle loss, researchers said. "We found that adults ...

By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...